Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7062219rdf:typepubmed:Citationlld:pubmed
pubmed-article:7062219lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:7062219lifeskim:mentionsumls-concept:C0031330lld:lifeskim
pubmed-article:7062219lifeskim:mentionsumls-concept:C0041044lld:lifeskim
pubmed-article:7062219pubmed:issue4lld:pubmed
pubmed-article:7062219pubmed:dateCreated1982-5-21lld:pubmed
pubmed-article:7062219pubmed:abstractTextThe pharmacokinetic parameters of sulfamethoxazole and trimethoprim were measured in 12 newborn infants of less than 3 days postnatal age, following a single or repeated intravenous injection. The mean half-lives for SMZ and TMP were 16.5 hours and 19.0 hours, respectively. The mean volumes of distribution were SMZ 0.48 L/kg and TMP 2.7 L/kg. The mean drug clearances were SMZ 0.65 ml/minute and TMP 3.31 ml/minute. From these data the recommended loading dose is SMZ 10 mg/kg with TMP 3 mg/kg, and the maintenance dose is SMZ 3 mg/kg with TMP 1 mg/kg twice daily. No adverse side effects were seen during treatment, and the bilirubin-binding capacity of albumin were not changed at therapeutic concentrations of the antimicrobial drugs.lld:pubmed
pubmed-article:7062219pubmed:languageenglld:pubmed
pubmed-article:7062219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7062219pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7062219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7062219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7062219pubmed:statusMEDLINElld:pubmed
pubmed-article:7062219pubmed:monthAprlld:pubmed
pubmed-article:7062219pubmed:issn0022-3476lld:pubmed
pubmed-article:7062219pubmed:authorpubmed-author:MichelJJlld:pubmed
pubmed-article:7062219pubmed:authorpubmed-author:EyalFFlld:pubmed
pubmed-article:7062219pubmed:authorpubmed-author:SpringerCClld:pubmed
pubmed-article:7062219pubmed:issnTypePrintlld:pubmed
pubmed-article:7062219pubmed:volume100lld:pubmed
pubmed-article:7062219pubmed:ownerNLMlld:pubmed
pubmed-article:7062219pubmed:authorsCompleteYlld:pubmed
pubmed-article:7062219pubmed:pagination647-50lld:pubmed
pubmed-article:7062219pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:meshHeadingpubmed-meshheading:7062219-...lld:pubmed
pubmed-article:7062219pubmed:year1982lld:pubmed
pubmed-article:7062219pubmed:articleTitlePharmacology of trimethoprim-sulfamethoxazole in newborn infants.lld:pubmed
pubmed-article:7062219pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7062219lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7062219lld:pubmed